PlainRecalls
FDA Drug Moderate Class II Ongoing

Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02

Reported: May 14, 2025 Initiated: April 22, 2025 #D-0411-2025

Product Description

Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02

Reason for Recall

CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.

Details

Recalling Firm
RemedyRePack Inc.
Units Affected
23 bottles/30 count- 690 capsules
Distribution
Within U.S - PA, VA, FL.
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02. Recalled by RemedyRePack Inc.. Units affected: 23 bottles/30 count- 690 capsules.
Why was this product recalled?
CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 14, 2025. Severity: Moderate. Recall number: D-0411-2025.